Preferences of psychiatric practitioners for core symptoms of major depressive disorder: a hidden conjoint analysis

被引:3
|
作者
Riepe, Matthias W. [1 ]
Gritzmann, Peter [2 ]
Brieden, Andreas [3 ]
机构
[1] Univ Ulm, Div Mental Hlth & Old Age Psychiat, Psychiat 2, Ludwig Heilmeyer Str 2, D-89312 Gunzburg, Germany
[2] Tech Univ Munich, Dept Math, Munich, Germany
[3] Univ Bundeswehr Munchen, Dept Wirtschafts & Org Wissensch, Neubiberg, Germany
关键词
clinical relevance; clinical symptoms; disease severity; everyday function; symptom preferences; ANALYTIC HIERARCHY PROCESS; PATIENT PREFERENCES; RATING-SCALE; IMPAIRMENT; DISABILITY; VALIDITY; MADRS;
D O I
10.1002/mpr.1528
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
According to ICD-10 and DSM-V, symptoms of depressive disorder are considered to be equally important for severity judgment. It was the goal to investigate the weight of selected symptom complexes for severity judgment. In workaday life severity judgment results from an overall impression rather than from calculating severity in different symptom complexes, separately. In fact, the drivers for overall judgment may not be known explicitly to the psychiatrist himself. A method of choice to resolve this is conjoint analysis. Based on the Montgomery-Asberg Depression Scale (MADRS) and the Sheehan Disability Scale (SDS) case vignettes were constructed. Different symptom severity in the domains mood, vegetative symptoms, cognition/inhibition, suicidality, and everyday functioning were worked into the vignettes. Different symptom complexes influence the severity judgment by clinical psychiatrists to a rather different extent. Mood has a greater impact on severity judgment than suicidality, cognition/inhibition, vegetative symptoms, and everyday functioning. We conclude that core complexes of major depressive disorder are valued with different clinical relevance by psychiatrists. Thus, diagnosis and appraisal of therapeutic efficacy are subject to individual preferences of clinical psychiatrists and prevalence and therapeutic efficacy may be over- or under-estimated unless these differences in preferences are taken into account.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Hypofrontality in major depressive disorder: Relationship to psychiatric symptoms
    Galynker, I
    Cai, J
    Dutta, E
    Serseni, D
    Miner, C
    Ongseng, F
    Gallagher, R
    [J]. BIOLOGICAL PSYCHIATRY, 1996, 39 (07) : 350 - 350
  • [2] An IRT Analysis of the Symptoms of Major Depressive Disorder
    Emmert-Aronson, Benjamin O.
    Brown, Timothy A.
    [J]. ASSESSMENT, 2015, 22 (03) : 332 - 340
  • [3] Core Symptoms of Major Depressive Disorder among Palliative Care Patients
    Huey, Ng Su
    Guan, Ng Chong
    Gill, Jesjeet Singh
    Hui, Koh Ong
    Sulaiman, Ahmad Hatim
    Kanagasundram, Sharmilla
    [J]. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2018, 15 (08):
  • [4] Vortioxetine in the treatment of major depressive disorder, addressing the core and residual symptoms
    Romero Guillena, S. L.
    Plasencia Garcia de Diego, B. O.
    Gotor Sanchez-Luengo, F.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S35 - S36
  • [5] Major depressive disorder and depressive symptoms in intermittent explosive disorder
    Medeiros, Gustavo C.
    Seger, Liliana
    Grant, Jon E.
    Tavares, Herman
    [J]. PSYCHIATRY RESEARCH, 2018, 262 : 209 - 212
  • [6] Analysis of Depressive Symptoms in Patients With Major Depressive Disorder Treated With Desvenlafaxine or Placebo
    Kornstein, Susan G.
    Fava, Maurizio
    Jiang, Qin
    Tourian, Karen A.
    [J]. PSYCHOPHARMACOLOGY BULLETIN, 2009, 42 (03) : 21 - 35
  • [7] Cognition - the core of major depressive disorder
    Polosan, M.
    Lemogne, C.
    Jardri, R.
    Fossati, P.
    [J]. ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2016, 42 : S3 - S11
  • [8] Psychiatric comorbidities in patients with major depressive disorder
    Thaipisuttikul, Papan
    Ittasakul, Pichai
    Waleeprakhon, Punjaporn
    Wisajun, Pattarabhorn
    Jullagate, Sudawan
    [J]. NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2014, 10 : 2097 - 2103
  • [9] Psychiatric comorbidities in patients with major depressive disorder
    Thaipisuttikul, P.
    Ittasakul, P.
    Waleeprakhon, P.
    Wisajun, P.
    Jullagate, S.
    [J]. ASIA-PACIFIC PSYCHIATRY, 2015, 7 : 11 - 11
  • [10] Use of Non-Psychiatric Medications With Potential Depressive Symptom Side Effects and Level of Depressive Symptoms in Major Depressive Disorder
    Mojtabai, Ramin
    Amin-Esmaeili, Masoumeh
    Spivak, Stanislav
    Olfson, Mark
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2023, 84 (04)